These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24089700)

  • 1. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders.
    Sharma HS; Muresanu DF; Sharma A
    Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5th Annual Global College of Neuroprotection and Neuroregeneration.
    Sharma HS
    Expert Rev Neurother; 2008 Jun; 8(6):881-7. PubMed ID: 18505353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6th Global College of Neuroprotection and Neuroregeneration, annual meeting.
    Sharma HS; Sharma A
    Expert Rev Neurother; 2009 Jul; 9(7):941-7. PubMed ID: 19589044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic advances in CNS injury and repair.
    Sharma HS; Sharma A
    Expert Rev Neurother; 2012 Aug; 12(8):901-5. PubMed ID: 23002933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents.
    Sharma HS; Sharma A
    Expert Rev Neurother; 2011 Aug; 11(8):1121-4. PubMed ID: 21797653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders.
    Farin A; Liu CY; Langmoen IA; Apuzzo ML
    Neurosurgery; 2009 Nov; 65(5):831-59; discussion 859. PubMed ID: 19834396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.
    Sharma HS; Sharma A
    Amino Acids; 2013 Nov; 45(5):1055-71. PubMed ID: 24022705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual advances in neurorestoratology: a summary of IANR VI and 10th GCNN conference, Bucharest, Romania, April 4-7, 2013.
    Chen L; Sharma A; Guo J; Muresanu D; Huang H; Skaper S; Sharma HS
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):547-9. PubMed ID: 23746136
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
    Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
    Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors.
    Sharma HS; Sharma A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(2):184-203. PubMed ID: 22162425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue-derived stem cells in neural regenerative medicine.
    Yeh DC; Chan TM; Harn HJ; Chiou TW; Chen HS; Lin ZS; Lin SZ
    Cell Transplant; 2015; 24(3):487-92. PubMed ID: 25647067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
    Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and prospects: stem cells and neurological diseases.
    Gögel S; Gubernator M; Minger SL
    Gene Ther; 2011 Jan; 18(1):1-6. PubMed ID: 20882052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secretome of mesenchymal stem cells: potential implications for neuroregeneration.
    Paul G; Anisimov SV
    Biochimie; 2013 Dec; 95(12):2246-56. PubMed ID: 23871834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part II.
    Sharma HS; Sharma A
    Expert Rev Neurother; 2010 Aug; 10(8):1253-7. PubMed ID: 20662749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-drug delivery and neuroprotection in spinal cord injury.
    Sharma HS; Ali S; Tian ZR; Patnaik R; Patnaik S; Lek P; Sharma A; Lundstedt T
    J Nanosci Nanotechnol; 2009 Aug; 9(8):5014-37. PubMed ID: 19928182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing face of neural stem cell therapy in neurologic diseases.
    Einstein O; Ben-Hur T
    Arch Neurol; 2008 Apr; 65(4):452-6. PubMed ID: 18413466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.